Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis

被引：0
|
作者：
Jian Luo
Ke Wang
Dan Liu
Bin-Miao Liang
Chun-Tao Liu
机构：
[1] Sichuan University,Department of Respiratory and Critical Care Medicine
[2] Sichuan University,Department of Critical Care Medicine, West China School of Medicine and West China Hospital
来源：
Respiratory Research | / 17卷
关键词：
Roflumilast; Chronic obstructive pulmonary disease; Lung function; Exacerbation; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Assessment of automated analysis of portable oximetry as a screening test for moderate-to-severe sleep apnea in patients with chronic obstructive pulmonary disease
    Andres-Blanco, Ana M.
    Alvarez, Daniel
    Crespo, Andrea
    Arroyo, C. Ainhoa
    Cerezo-Hernandez, Ana
    Gutierrez-Tobal, Gonzalo C.
    Hornero, Roberto
    del Campo, Felix
    PLOS ONE, 2017, 12 (11):
  • [42] Effects of influenza vaccination on clinical outcomes of chronic obstructive pulmonary disease: A systematic review and meta-analysis
    Bao, Wanying
    Li, Ya
    Wang, Tao
    Li, Xiaoou
    He, Junyun
    Wang, Yashu
    Wen, Fuqiang
    Chen, Jun
    AGEING RESEARCH REVIEWS, 2021, 68
  • [43] Meta-analysis of peripheral blood eosinophils in clinical testing of chronic obstructive pulmonary disease patients
    Zhang, Chunmei
    Song, Jie
    Wang, Jinxiang
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2024, 41 (02): : 155 - 163
  • [44] Remotely monitored Baduanjin exercise in moderate-to-severe chronic obstructive pulmonary disease patients (BROCADE): A study protocol
    Xu, Shuanglan
    Yin, Zhifei
    Chen, Zi
    Zhang, Dandan
    Ye, Sheng
    Zhou, Ping
    Chen, Aiping
    Wu, Di
    Liu, Weihua
    Zhang, Liuchao
    Guo, Liquan
    Xu, Guangxu
    Zhou, Linfu
    MEDICINE, 2022, 101 (52) : E32079
  • [45] Efficacy and safety of four doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor (PDE4i), in patients with moderate-to-severe COPD
    Singh, Dave
    Nandeuil, Marie Anna
    Pigeon-Francisco, Catherine
    Emirova, Aida
    Santoro, Debora
    Biondaro, Sonia
    Govoni, Mirco
    Petruzzelli, Stefano
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [46] ECONOMIC BURDEN OF PATIENTS IN THE UNITED STATES WITH MODERATE-TO-SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A FOCUSED LITERATURE REVIEW
    Herrera, Mayen E.
    Stanford, R.
    Njue, A.
    Lyall, M.
    Nuabor, W.
    D'Souza, V
    Dubucq, H.
    Moola, S.
    VALUE IN HEALTH, 2023, 26 (12) : S553 - S553
  • [47] The impact of noninvasive ventilation during the physical training in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD)
    Toledo, Andreza
    Borghi-Silva, Audrey
    Malosa Sampaio, Luciana Maria
    Ribeiro, Karla Paiva
    Baldissera, Vilmar
    Costa, Dirceu
    CLINICS, 2007, 62 (02) : 113 - 120
  • [48] Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review
    John R. Hurst
    MeiLan K. Han
    Barinder Singh
    Sakshi Sharma
    Gagandeep Kaur
    Enrico de Nigris
    Ulf Holmgren
    Mohd Kashif Siddiqui
    Respiratory Research, 23
  • [49] Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review
    Hurst, John R.
    Han, MeiLan K.
    Singh, Barinder
    Sharma, Sakshi
    Kaur, Gagandeep
    de Nigris, Enrico
    Holmgren, Ulf
    Siddiqui, Mohd Kashif
    RESPIRATORY RESEARCH, 2022, 23 (01)
  • [50] Cost-Effectiveness Analysis of Triple Combination Preparations in the Treatment of Moderate-to-Severe Chronic Obstructive Pulmonary Disease
    Zhou, Yikang
    Long, Enwu
    Xu, Qian
    Wang, Lei
    Jiang, Xuehua
    Hu, Ming
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
12345